This is a preview of subscription content, log in via an institution to check access.
Notes
based on prognostic factors including erosions, rheumatoid factor or anticitrullinated cyclic peptide positivity and Disease Activity Score in 28 joints
2018 euros
Reference
Pazmino S, et al. Two-year cost-effectiveness of different COBRA-like intensive remission induction schemes in early rheumatoid arthritis: a piggyback study on the pragmatic randomised controlled CareRA trial. Annals of the Rheumatic Diseases : 2 Apr 2020. Available from: URL: http://doi.org/10.1136/annrheumdis-2019-216874
Rights and permissions
About this article
Cite this article
MTX plus glucocorticoid less costly than intensive combinations. PharmacoEcon Outcomes News 851, 32 (2020). https://doi.org/10.1007/s40274-020-6755-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-6755-z